Literature DB >> 15712014

HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine.

Inna G Ovsyannikova1, Robert M Jacobson, Jenna E Ryan, Robert A Vierkant, V Shane Pankratz, Steven J Jacobsen, Gregory A Poland.   

Abstract

Measles virus-specific T cells and the production of cytokines play a critical role in the immune response following measles immunization. To understand the genetic factors that influence variation in IFN-gamma and IL-4 responses following measles immunization and to provide insight into the factors influencing both cellular and humoral immunity to measles, we assessed associations between human leukocyte antigen (HLA) class II genes and measles-specific Th1 and Th2-type cytokine responses in peripheral blood lymphocytes from 339 children previously vaccinated with two doses of measles-mumps-rubella vaccine (MMR-II). Median values for measles-specific IFN-gamma and IL-4 secretion levels were 40.73 and 9.71 pg/ml, respectively. The global tests suggested associations between measles-specific IFN-gamma response and alleles of the DRB1 and DQB1 loci (P=0.07 and P=0.02, respectively). Specifically, DRB1*0301, *0901, and *1501 alleles were significantly associated with IFN-gamma secretion. The alleles that suggested evidence of an HLA association with IL-4 secretion were DRB1*0103, *0701, and *1101. Th1 cytokine responses and DQB1 allele associations revealed that the alleles with the strongest association with IFN-gamma secretion were DQB1*0201, *0303, *0402, and *0602. Specific alleles with a suggestive association with low measles-specific Th2 cytokine responses were DQB1*0202 and *0503. In addition, DPB1*0101, *0201, and *0601 alleles provided suggestive evidence of an HLA association with measles-induced IFN-gamma response, while DPB1*0501 was associated with an IL-4 response. These data suggest that IFN-gamma and IL-4 cytokine responses to measles may be genetically restricted in part by HLA class II genes, which in turn can restrict the cellular immune response to measles vaccine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15712014     DOI: 10.1007/s00251-004-0756-0

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  38 in total

1.  Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line.

Authors:  J C Gorga; V Horejsí; D R Johnson; R Raghupathy; J L Strominger
Journal:  J Biol Chem       Date:  1987-11-25       Impact factor: 5.157

2.  Changes in intracellular cytokine levels in lymphocytes induced by measles virus.

Authors:  M Ito; M Watanabe; H Kamiya; M Sakurai
Journal:  Clin Immunol Immunopathol       Date:  1997-06

3.  Presentation of an immunodominant T-cell epitope of hepatitis B surface antigen by the HLA-DPw4 molecule.

Authors:  E Celis; R W Karr
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

4.  Immune modulation after measles vaccination of 6-9 months old Bangladeshi infants.

Authors:  J J Schnorr; F T Cutts; J G Wheeler; S M Akramuzzaman; M S Alam; T Azim; S Schneider-Schaulies; V ter-Meulen
Journal:  Vaccine       Date:  2001-01-08       Impact factor: 3.641

5.  Polymorphic nucleotides within the human IL-4 promoter that mediate overexpression of the gene.

Authors:  Z Song; V Casolaro; R Chen; S N Georas; D Monos; S J Ono
Journal:  J Immunol       Date:  1996-01-15       Impact factor: 5.422

6.  DNA restriction fragment length polymorphism of HLA-DR2: correlation with HLA-DR2-associated functions.

Authors:  S Jacobson; R Sorrentino; G T Nepom; D E McFarlin; J L Strominger
Journal:  J Neuroimmunol       Date:  1986-09       Impact factor: 3.478

7.  Immune activation in measles.

Authors:  D E Griffin; B J Ward; E Jauregui; R T Johnson; A Vaisberg
Journal:  N Engl J Med       Date:  1989-06-22       Impact factor: 91.245

8.  Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination.

Authors:  Inna G Ovsyannikova; Robert M Jacobson; Robert A Vierkant; V Shane Pankratz; Steven J Jacobsen; Gregory A Poland
Journal:  Vaccine       Date:  2004-05-07       Impact factor: 3.641

9.  Preferential recognition of hepatitis B nucleocapsid antigens by Th1 or Th2 cells is epitope and major histocompatibility complex dependent.

Authors:  D R Milich; D L Peterson; F Schödel; J E Jones; J L Hughes
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

10.  Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens.

Authors:  S Jacobson; J R Richert; W E Biddison; A Satinsky; R J Hartzman; H F McFarland
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

View more
  30 in total

1.  Genome-wide genetic associations with IFNγ response to smallpox vaccine.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; V Shane Pankratz; Iana H Haralambieva; Robert A Vierkant; Robert M Jacobson; Gregory A Poland
Journal:  Hum Genet       Date:  2012-06-03       Impact factor: 4.132

2.  Optimizing high dimensional gene expression studies for immune response following smallpox vaccination using Taqman® low density immune arrays.

Authors:  Ann L Oberg; Neelam Dhiman; Diane E Grill; Jenna E Ryan; Richard B Kennedy; Gregory A Poland
Journal:  J Immunol Methods       Date:  2011-01-28       Impact factor: 2.303

3.  Correlations between vaccinia-specific immune responses within a cohort of armed forces members.

Authors:  Benjamin J Umlauf; Inna G Ovsyannikova; Iana H Haralambieva; Richard B Kennedy; Robert A Vierkant; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Viral Immunol       Date:  2011-09-29       Impact factor: 2.257

4.  Consistency of HLA associations between two independent measles vaccine cohorts: a replication study.

Authors:  Inna G Ovsyannikova; V Shane Pankratz; Robert A Vierkant; Robert M Jacobson; Gregory A Poland
Journal:  Vaccine       Date:  2012-01-25       Impact factor: 3.641

5.  Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; V Shane Pankratz; Iana H Haralambieva; Robert A Vierkant; Gregory A Poland
Journal:  Hum Genet       Date:  2012-05-19       Impact factor: 4.132

Review 6.  Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Richard B Kennedy; Iana H Haralambieva; Robert M Jacobson
Journal:  OMICS       Date:  2011-07-06

7.  Multigenic control of measles vaccine immunity mediated by polymorphisms in measles receptor, innate pathway, and cytokine genes.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Iana H Haralambieva; Megan M O'Byrne; Robert M Jacobson; V Shane Pankratz; Gregory A Poland
Journal:  Vaccine       Date:  2012-01-20       Impact factor: 3.641

8.  HLA alleles associated with the adaptive immune response to smallpox vaccine: a replication study.

Authors:  Inna G Ovsyannikova; V Shane Pankratz; Hannah M Salk; Richard B Kennedy; Gregory A Poland
Journal:  Hum Genet       Date:  2014-06-01       Impact factor: 4.132

Review 9.  The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; V Shane Pankratz; Richard B Kennedy; Robert M Jacobson; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

Review 10.  Rabies-specific antibodies: measuring surrogates of protection against a fatal disease.

Authors:  Susan M Moore; Cathleen A Hanlon
Journal:  PLoS Negl Trop Dis       Date:  2010-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.